Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 1921 AL 1935

The effects of different types of Tai Chi exercises on motor function in patients with Parkinson's disease: A network meta-analysis

Lei H, Ma Z, Tian K, Liu K, Wang J, Zhu X, Mi B, Chen Y, Yang Q, Jiang H.

Front Aging Neurosci. 2022 Aug 29;14:936027. doi: 10.3389/fnagi.2022.936027. eCollection 2022.

Effects of mind-body exercises on cognitive impairment in people with Parkinson's disease: A mini-review

Zhang T, Liu W, Gao S.

Front Neurol. 2022 Sep 1;13:931460. doi: 10.3389/fneur.2022.931460. eCollection 2022.

Effectiveness of therapeutic massage for improving motor symptoms in Parkinson's disease: A systematic review and meta-analysis

Kang Z, Xing H, Lin Q, Meng F, Gong L.

Front Neurol. 2022 Sep 5;13:915232. doi: 10.3389/fneur.2022.915232. eCollection 2022.

Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson's Disease

Ahuja M, Kaidery NA, Dutta D, Attucks OC, Kazakov EH, Gazaryan I, Matsumoto M, Igarashi K, Sharma SM, Thomas B.

Antioxidants (Basel). 2022 Sep 9;11(9):1780. doi: 10.3390/antiox11091780.

The Role of Glymphatic System in Alzheimer's and Parkinson's Disease Pathogenesis

Buccellato FR, D'Anca M, Serpente M, Arighi A, Galimberti D.

Biomedicines. 2022 Sep 13;10(9):2261. doi: 10.3390/biomedicines10092261.

Molecular understanding of the translational models and the therapeutic potential natural products of Parkinson's disease

Pang M, Peng R, Wang Y, Zhu Y, Wang P, Moussian B, Su Y, Liu X, Ming D.

Biomed Pharmacother. 2022 Nov;155:113718. doi: 10.1016/j.biopha.2022.113718. Epub 2022 Sep 21.

Blood based biomarkers for movement disorders

Morris HR.

Acta Neurol Scand. 2022 Oct;146(4):353-361. doi: 10.1111/ane.13700.

How well do you know your dopamine antagonists?

2022 Oct. Perry T, editor. Therapeutics Letter. Vancouver (BC): Therapeutic Initiatives; 1994–. Letter 139.

Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial

Patterson CG, Joslin E, Gil AB, Spigle W, Nemet T, Chahine L, Christiansen CL, Melanson E, Kohrt WM, Mancini M, Josbeno D, Balfany K, Griffith G, Dunlap MK, Lamotte G, Suttman E, Larson D, Branson C, McKee KE, Goelz L, Poon C, Tilley B, Kang UJ, Tansey MG, Luthra N, Tanner CM, Haus JM, Fantuzzi G, McFarland NR, Gonzalez-Latapi P, Foroud T, Motl R, Schwarzschild MA, Simuni T, Marek K, Naito A, Lungu C, Corcos DM; SPARX3-PSG Investigators.

Trials. 2022 Oct 6;23(1):855. doi: 10.1186/s13063-022-06703-0.

Impact of Covid-19 on research and training in Parkinson's disease

Wan YM, van Wamelen DJ, Lau YH, Rota S, Tan EK.

Int Rev Neurobiol. 2022;165:283-305. doi: 10.1016/bs.irn.2022.04.003. Epub 2022 May 4.

Deep Brain Stimulation in the Treatment of Parkinson's Disease

Shah H, Usman O, Ur Rehman H, Jhaveri S, Avanthika C, Hussain K, Islam H, I S K S.

Cureus. 2022 Sep 3;14(9):e28760. doi: 10.7759/cureus.28760. eCollection 2022 Sep.

An update on advanced therapies for Parkinson's disease: From gene therapy to neuromodulation

Serva SN, Bernstein J, Thompson JA, Kern DS, Ojemann SG.

Front Surg. 2022 Sep 23;9:863921. doi: 10.3389/fsurg.2022.863921. eCollection 2022.

Community-based high-intensity cycling improves disease symptoms in individuals with Parkinson's disease: A six-month pragmatic observational study

Rosenfeldt AB, Miller Koop M, Penko AL, Hastilow K, Zimmerman E, Schindler D, Alberts JL.

Health Soc Care Community. 2022 Nov;30(6):e6122-e6134. doi: 10.1111/hsc.14049. Epub 2022 Oct 10.

Diagnosis and Medical Management of Parkinson Disease

Thaler A, Alcalay RN.

Continuum (Minneap Minn). 2022 Oct 1;28(5):1281-1300. doi: 10.1212/CON.0000000000001152.

Palliative Care and Movement Disorders

Katz M.

Continuum (Minneap Minn). 2022 Oct 1;28(5):1520-1529. doi: 10.1212/CON.0000000000001162.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias